nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SCN8A—cerebellar cortex—hypothyroidism	0.0598	0.122	CbGeAlD
Procainamide—SCN11A—nerve—hypothyroidism	0.0289	0.0592	CbGeAlD
Procainamide—SCN8A—nerve—hypothyroidism	0.0219	0.0448	CbGeAlD
Procainamide—SCN10A—nerve—hypothyroidism	0.0147	0.03	CbGeAlD
Procainamide—Oliguria—Liotrix—hypothyroidism	0.0118	0.0341	CcSEcCtD
Procainamide—Cardiac failure—Dextrothyroxine—hypothyroidism	0.011	0.0317	CcSEcCtD
Procainamide—Cardiac failure—Levothyroxine—hypothyroidism	0.011	0.0317	CcSEcCtD
Procainamide—SLC22A3—tongue—hypothyroidism	0.0104	0.0213	CbGeAlD
Procainamide—Cardiac arrest—Levothyroxine—hypothyroidism	0.0102	0.0294	CcSEcCtD
Procainamide—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.0102	0.0294	CcSEcCtD
Procainamide—Hypotension—Liothyronine—hypothyroidism	0.01	0.029	CcSEcCtD
Procainamide—Lightheadedness—Liotrix—hypothyroidism	0.00972	0.0281	CcSEcCtD
Procainamide—SCN7A—heart—hypothyroidism	0.00914	0.0187	CbGeAlD
Procainamide—SCN7A—cardiovascular system—hypothyroidism	0.00862	0.0176	CbGeAlD
Procainamide—Body temperature increased—Liothyronine—hypothyroidism	0.00848	0.0245	CcSEcCtD
Procainamide—Renal impairment—Liotrix—hypothyroidism	0.00829	0.0239	CcSEcCtD
Procainamide—Cardiac failure—Liotrix—hypothyroidism	0.00808	0.0233	CcSEcCtD
Procainamide—Cardiac arrest—Liotrix—hypothyroidism	0.0075	0.0217	CcSEcCtD
Procainamide—DNMT1—adrenal cortex—hypothyroidism	0.00726	0.0148	CbGeAlD
Procainamide—CYP2D6—urine—hypothyroidism	0.00725	0.0148	CbGeAlD
Procainamide—DNMT1—heart—hypothyroidism	0.00702	0.0144	CbGeAlD
Procainamide—Flushing—Levothyroxine—hypothyroidism	0.00688	0.0199	CcSEcCtD
Procainamide—Flushing—Dextrothyroxine—hypothyroidism	0.00688	0.0199	CcSEcCtD
Procainamide—SCN7A—adrenal gland—hypothyroidism	0.00682	0.0139	CbGeAlD
Procainamide—DNMT1—cardiovascular system—hypothyroidism	0.00662	0.0135	CbGeAlD
Procainamide—SCN7A—thyroid gland—hypothyroidism	0.00658	0.0135	CbGeAlD
Procainamide—SCN4A—heart—hypothyroidism	0.00638	0.0131	CbGeAlD
Procainamide—SCN7A—female gonad—hypothyroidism	0.00636	0.013	CbGeAlD
Procainamide—ACHE—Monoamine Transport—SLC5A7—hypothyroidism	0.00608	0.0369	CbGpPWpGaD
Procainamide—DNMT1—gonad—hypothyroidism	0.00601	0.0123	CbGeAlD
Procainamide—SCN9A—pituitary gland—hypothyroidism	0.00598	0.0122	CbGeAlD
Procainamide—Renal failure—Liotrix—hypothyroidism	0.00597	0.0173	CcSEcCtD
Procainamide—Angioedema—Levothyroxine—hypothyroidism	0.0059	0.017	CcSEcCtD
Procainamide—Angioedema—Dextrothyroxine—hypothyroidism	0.0059	0.017	CcSEcCtD
Procainamide—DNMT1—pituitary gland—hypothyroidism	0.00586	0.012	CbGeAlD
Procainamide—ACHE—heart—hypothyroidism	0.0057	0.0117	CbGeAlD
Procainamide—SCN7A—testis—hypothyroidism	0.00564	0.0115	CbGeAlD
Procainamide—Convulsion—Levothyroxine—hypothyroidism	0.00559	0.0162	CcSEcCtD
Procainamide—Convulsion—Dextrothyroxine—hypothyroidism	0.00559	0.0162	CcSEcCtD
Procainamide—Arthralgia—Levothyroxine—hypothyroidism	0.0055	0.0159	CcSEcCtD
Procainamide—Arthralgia—Dextrothyroxine—hypothyroidism	0.0055	0.0159	CcSEcCtD
Procainamide—SCN9A—adrenal gland—hypothyroidism	0.00534	0.0109	CbGeAlD
Procainamide—SCN4A—pituitary gland—hypothyroidism	0.00533	0.0109	CbGeAlD
Procainamide—SCN7A—liver—hypothyroidism	0.00533	0.0109	CbGeAlD
Procainamide—Confusional state—Levothyroxine—hypothyroidism	0.00531	0.0153	CcSEcCtD
Procainamide—Confusional state—Dextrothyroxine—hypothyroidism	0.00531	0.0153	CcSEcCtD
Procainamide—DNMT1—adrenal gland—hypothyroidism	0.00524	0.0107	CbGeAlD
Procainamide—DNMT1—blood—hypothyroidism	0.00524	0.0107	CbGeAlD
Procainamide—Shock—Levothyroxine—hypothyroidism	0.00518	0.015	CcSEcCtD
Procainamide—Shock—Dextrothyroxine—hypothyroidism	0.00518	0.015	CcSEcCtD
Procainamide—SLC22A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.0051	0.0309	CbGpPWpGaD
Procainamide—Flushing—Liotrix—hypothyroidism	0.00506	0.0146	CcSEcCtD
Procainamide—DNMT1—thyroid gland—hypothyroidism	0.00505	0.0103	CbGeAlD
Procainamide—SCN8A—testis—hypothyroidism	0.00503	0.0103	CbGeAlD
Procainamide—SCN3A—heart—hypothyroidism	0.00497	0.0102	CbGeAlD
Procainamide—SCN5A—heart—hypothyroidism	0.00495	0.0101	CbGeAlD
Procainamide—DNMT1—female gonad—hypothyroidism	0.00488	0.00999	CbGeAlD
Procainamide—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.0048	0.0139	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.0048	0.0139	CcSEcCtD
Procainamide—SCN4A—adrenal gland—hypothyroidism	0.00476	0.00974	CbGeAlD
Procainamide—SLC22A1—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00475	0.0288	CbGpPWpGaD
Procainamide—SCN2A—pituitary gland—hypothyroidism	0.00472	0.00965	CbGeAlD
Procainamide—SCN5A—cardiovascular system—hypothyroidism	0.00467	0.00955	CbGeAlD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—NKX2-5—hypothyroidism	0.00467	0.0284	CbGpPWpGaD
Procainamide—Dysgeusia—Liotrix—hypothyroidism	0.00465	0.0134	CcSEcCtD
Procainamide—SCN8A—cerebellum—hypothyroidism	0.00464	0.00949	CbGeAlD
Procainamide—SCN4A—thyroid gland—hypothyroidism	0.0046	0.0094	CbGeAlD
Procainamide—SCN10A—pituitary gland—hypothyroidism	0.00455	0.00931	CbGeAlD
Procainamide—SCN9A—testis—hypothyroidism	0.00442	0.00903	CbGeAlD
Procainamide—SLC22A4—heart—hypothyroidism	0.00435	0.00889	CbGeAlD
Procainamide—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00434	0.0125	CcSEcCtD
Procainamide—Feeling abnormal—Levothyroxine—hypothyroidism	0.00434	0.0125	CcSEcCtD
Procainamide—Angioedema—Liotrix—hypothyroidism	0.00434	0.0125	CcSEcCtD
Procainamide—DNMT1—testis—hypothyroidism	0.00433	0.00886	CbGeAlD
Procainamide—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00431	0.0124	CcSEcCtD
Procainamide—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00431	0.0124	CcSEcCtD
Procainamide—ACHE—adrenal gland—hypothyroidism	0.00426	0.0087	CbGeAlD
Procainamide—SCN2A—blood—hypothyroidism	0.00422	0.00862	CbGeAlD
Procainamide—CHRM2—heart—hypothyroidism	0.00422	0.00862	CbGeAlD
Procainamide—SLC22A4—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00421	0.0256	CbGpPWpGaD
Procainamide—Urticaria—Dextrothyroxine—hypothyroidism	0.00419	0.0121	CcSEcCtD
Procainamide—Urticaria—Levothyroxine—hypothyroidism	0.00419	0.0121	CcSEcCtD
Procainamide—Body temperature increased—Levothyroxine—hypothyroidism	0.00417	0.012	CcSEcCtD
Procainamide—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00417	0.012	CcSEcCtD
Procainamide—Abdominal pain—Levothyroxine—hypothyroidism	0.00417	0.012	CcSEcCtD
Procainamide—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00417	0.012	CcSEcCtD
Procainamide—SCN3A—pituitary gland—hypothyroidism	0.00415	0.00848	CbGeAlD
Procainamide—Convulsion—Liotrix—hypothyroidism	0.00412	0.0119	CcSEcCtD
Procainamide—ACHE—thyroid gland—hypothyroidism	0.00411	0.0084	CbGeAlD
Procainamide—DNMT1—liver—hypothyroidism	0.0041	0.00837	CbGeAlD
Procainamide—SCN10A—blood—hypothyroidism	0.00407	0.00831	CbGeAlD
Procainamide—Arthralgia—Liotrix—hypothyroidism	0.00404	0.0117	CcSEcCtD
Procainamide—DNMT1—cerebellum—hypothyroidism	0.004	0.00818	CbGeAlD
Procainamide—CHRM2—cardiovascular system—hypothyroidism	0.00398	0.00813	CbGeAlD
Procainamide—DNMT1—Regulation of retinoblastoma protein—BGLAP—hypothyroidism	0.00396	0.0241	CbGpPWpGaD
Procainamide—SCN4A—testis—hypothyroidism	0.00394	0.00806	CbGeAlD
Procainamide—Confusional state—Liotrix—hypothyroidism	0.00391	0.0113	CcSEcCtD
Procainamide—SLC22A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00389	0.0236	CbGpPWpGaD
Procainamide—Shock—Liotrix—hypothyroidism	0.00381	0.011	CcSEcCtD
Procainamide—Asthenia—Dextrothyroxine—hypothyroidism	0.00378	0.0109	CcSEcCtD
Procainamide—Asthenia—Levothyroxine—hypothyroidism	0.00378	0.0109	CcSEcCtD
Procainamide—Pruritus—Dextrothyroxine—hypothyroidism	0.00373	0.0108	CcSEcCtD
Procainamide—Pruritus—Levothyroxine—hypothyroidism	0.00373	0.0108	CcSEcCtD
Procainamide—SCN3A—adrenal gland—hypothyroidism	0.00371	0.00758	CbGeAlD
Procainamide—SCN3A—blood—hypothyroidism	0.00371	0.00758	CbGeAlD
Procainamide—Anorexia—Liotrix—hypothyroidism	0.00369	0.0107	CcSEcCtD
Procainamide—SCN5A—blood—hypothyroidism	0.00369	0.00755	CbGeAlD
Procainamide—SLC22A3—Synaptic Vesicle Pathway—CLTC—hypothyroidism	0.00368	0.0224	CbGpPWpGaD
Procainamide—SLC22A4—pituitary gland—hypothyroidism	0.00363	0.00743	CbGeAlD
Procainamide—SLC22A1—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00363	0.022	CbGpPWpGaD
Procainamide—Hypotension—Liotrix—hypothyroidism	0.00362	0.0105	CcSEcCtD
Procainamide—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00361	0.0104	CcSEcCtD
Procainamide—Diarrhoea—Levothyroxine—hypothyroidism	0.00361	0.0104	CcSEcCtD
Procainamide—SCN3A—thyroid gland—hypothyroidism	0.00358	0.00731	CbGeAlD
Procainamide—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00353	0.0102	CcSEcCtD
Procainamide—ACHE—testis—hypothyroidism	0.00352	0.0072	CbGeAlD
Procainamide—SCN1A—cerebellum—hypothyroidism	0.00351	0.00718	CbGeAlD
Procainamide—SLC22A3—gonad—hypothyroidism	0.00339	0.00693	CbGeAlD
Procainamide—Decreased appetite—Liotrix—hypothyroidism	0.00337	0.00973	CcSEcCtD
Procainamide—Vomiting—Dextrothyroxine—hypothyroidism	0.00335	0.00968	CcSEcCtD
Procainamide—Vomiting—Levothyroxine—hypothyroidism	0.00335	0.00968	CcSEcCtD
Procainamide—ACHE—cerebellum—hypothyroidism	0.00325	0.00665	CbGeAlD
Procainamide—SLC22A4—adrenal gland—hypothyroidism	0.00325	0.00664	CbGeAlD
Procainamide—SLC22A4—blood—hypothyroidism	0.00324	0.00663	CbGeAlD
Procainamide—SCN2A—cerebellum—hypothyroidism	0.00322	0.00659	CbGeAlD
Procainamide—Feeling abnormal—Liotrix—hypothyroidism	0.00319	0.00923	CcSEcCtD
Procainamide—SLC22A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00318	0.0193	CbGpPWpGaD
Procainamide—Gastrointestinal pain—Liotrix—hypothyroidism	0.00317	0.00916	CcSEcCtD
Procainamide—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00317	0.0192	CbGpPWpGaD
Procainamide—SLC22A4—thyroid gland—hypothyroidism	0.00313	0.0064	CbGeAlD
Procainamide—Nausea—Levothyroxine—hypothyroidism	0.00313	0.00904	CcSEcCtD
Procainamide—Nausea—Dextrothyroxine—hypothyroidism	0.00313	0.00904	CcSEcCtD
Procainamide—SLC22A1—blood—hypothyroidism	0.00309	0.00632	CbGeAlD
Procainamide—Urticaria—Liotrix—hypothyroidism	0.00308	0.00889	CcSEcCtD
Procainamide—SCN3A—testis—hypothyroidism	0.00307	0.00627	CbGeAlD
Procainamide—Abdominal pain—Liotrix—hypothyroidism	0.00306	0.00885	CcSEcCtD
Procainamide—Body temperature increased—Liotrix—hypothyroidism	0.00306	0.00885	CcSEcCtD
Procainamide—SLC22A5—adrenal cortex—hypothyroidism	0.00298	0.00608	CbGeAlD
Procainamide—SLC22A3—adrenal gland—hypothyroidism	0.00295	0.00604	CbGeAlD
Procainamide—SLC22A5—heart—hypothyroidism	0.00288	0.00588	CbGeAlD
Procainamide—Hypersensitivity—Liotrix—hypothyroidism	0.00286	0.00825	CcSEcCtD
Procainamide—SLC22A3—thyroid gland—hypothyroidism	0.00285	0.00583	CbGeAlD
Procainamide—SCN3A—cerebellum—hypothyroidism	0.00283	0.00579	CbGeAlD
Procainamide—BCHE—heart—hypothyroidism	0.0028	0.00573	CbGeAlD
Procainamide—Asthenia—Liotrix—hypothyroidism	0.00278	0.00803	CcSEcCtD
Procainamide—SCN5A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00276	0.0168	CbGpPWpGaD
Procainamide—SLC22A3—female gonad—hypothyroidism	0.00275	0.00563	CbGeAlD
Procainamide—Pruritus—Liotrix—hypothyroidism	0.00274	0.00792	CcSEcCtD
Procainamide—Diarrhoea—Liotrix—hypothyroidism	0.00265	0.00766	CcSEcCtD
Procainamide—BCHE—cardiovascular system—hypothyroidism	0.00264	0.00541	CbGeAlD
Procainamide—Dizziness—Liotrix—hypothyroidism	0.00256	0.0074	CcSEcCtD
Procainamide—SLC22A4—cerebellum—hypothyroidism	0.00248	0.00507	CbGeAlD
Procainamide—Vomiting—Liotrix—hypothyroidism	0.00246	0.00712	CcSEcCtD
Procainamide—SLC22A3—testis—hypothyroidism	0.00244	0.00499	CbGeAlD
Procainamide—SLC22A1—liver—hypothyroidism	0.00242	0.00494	CbGeAlD
Procainamide—SLC22A5—pituitary gland—hypothyroidism	0.0024	0.00492	CbGeAlD
Procainamide—BCHE—pituitary gland—hypothyroidism	0.00234	0.00479	CbGeAlD
Procainamide—SLC22A3—liver—hypothyroidism	0.00231	0.00472	CbGeAlD
Procainamide—Nausea—Liotrix—hypothyroidism	0.0023	0.00665	CcSEcCtD
Procainamide—SLC22A5—adrenal gland—hypothyroidism	0.00215	0.00439	CbGeAlD
Procainamide—SLC22A5—blood—hypothyroidism	0.00215	0.00439	CbGeAlD
Procainamide—SCN7A—Axon guidance—CLTC—hypothyroidism	0.00212	0.0129	CbGpPWpGaD
Procainamide—BCHE—adrenal gland—hypothyroidism	0.00209	0.00428	CbGeAlD
Procainamide—BCHE—blood—hypothyroidism	0.00209	0.00428	CbGeAlD
Procainamide—SLC22A5—thyroid gland—hypothyroidism	0.00207	0.00424	CbGeAlD
Procainamide—ACHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	0.00203	0.0123	CbGpPWpGaD
Procainamide—BCHE—thyroid gland—hypothyroidism	0.00202	0.00413	CbGeAlD
Procainamide—SLC22A5—female gonad—hypothyroidism	0.002	0.00409	CbGeAlD
Procainamide—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00199	0.0121	CbGpPWpGaD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00192	0.0116	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—CLTC—hypothyroidism	0.00189	0.0115	CbGpPWpGaD
Procainamide—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00186	0.0113	CbGpPWpGaD
Procainamide—BCHE—Synthesis, secretion, and deacylation of Ghrelin—IGF1—hypothyroidism	0.00181	0.011	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00178	0.0108	CbGpPWpGaD
Procainamide—SLC22A5—testis—hypothyroidism	0.00178	0.00363	CbGeAlD
Procainamide—BCHE—testis—hypothyroidism	0.00173	0.00354	CbGeAlD
Procainamide—SCN8A—Axon guidance—CLTC—hypothyroidism	0.00173	0.0105	CbGpPWpGaD
Procainamide—SLC22A5—liver—hypothyroidism	0.00168	0.00343	CbGeAlD
Procainamide—SLC22A5—cerebellum—hypothyroidism	0.00164	0.00335	CbGeAlD
Procainamide—BCHE—liver—hypothyroidism	0.00164	0.00334	CbGeAlD
Procainamide—DNMT1—Gene Expression—ZNF764—hypothyroidism	0.00161	0.00977	CbGpPWpGaD
Procainamide—BCHE—cerebellum—hypothyroidism	0.0016	0.00327	CbGeAlD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00159	0.00963	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—CLTC—hypothyroidism	0.00151	0.00918	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—TSHB—hypothyroidism	0.00148	0.00901	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00144	0.00877	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00144	0.00874	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00143	0.00866	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.0014	0.00851	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—CLTC—hypothyroidism	0.0014	0.00848	CbGpPWpGaD
Procainamide—CYP2D6—blood—hypothyroidism	0.00139	0.00283	CbGeAlD
Procainamide—SCN11A—Developmental Biology—CLTC—hypothyroidism	0.00135	0.00818	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—CLTC—hypothyroidism	0.00134	0.00811	CbGpPWpGaD
Procainamide—BCHE—Peptide hormone metabolism—TSHB—hypothyroidism	0.00132	0.00804	CbGpPWpGaD
Procainamide—CYP2D6—female gonad—hypothyroidism	0.00129	0.00264	CbGeAlD
Procainamide—SCN2A—Axon guidance—CLTC—hypothyroidism	0.00128	0.0078	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—CLTC—hypothyroidism	0.00128	0.0078	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00125	0.0076	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—CLTC—hypothyroidism	0.00124	0.00752	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—CLTC—hypothyroidism	0.00124	0.00752	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—CLTC—hypothyroidism	0.00123	0.00748	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.0012	0.00727	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00119	0.00724	CbGpPWpGaD
Procainamide—CYP2D6—testis—hypothyroidism	0.00115	0.00234	CbGeAlD
Procainamide—SLC22A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00112	0.00678	CbGpPWpGaD
Procainamide—CYP2D6—liver—hypothyroidism	0.00108	0.00222	CbGeAlD
Procainamide—SCN5A—Cardiac Progenitor Differentiation—IGF1—hypothyroidism	0.00108	0.00653	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—SLC5A7—hypothyroidism	0.00107	0.00652	CbGpPWpGaD
Procainamide—CYP2D6—cerebellum—hypothyroidism	0.00106	0.00216	CbGeAlD
Procainamide—SLC22A1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00104	0.00632	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—THRA—hypothyroidism	0.00104	0.0063	CbGpPWpGaD
Procainamide—SCN7A—Axon guidance—VAV3—hypothyroidism	0.000999	0.00606	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CLTC—hypothyroidism	0.000997	0.00605	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000973	0.00591	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—SLC5A7—hypothyroidism	0.000959	0.00582	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CLTC—hypothyroidism	0.000954	0.00579	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.000919	0.00558	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CLTC—hypothyroidism	0.000916	0.00556	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CLTC—hypothyroidism	0.000916	0.00556	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000906	0.0055	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000904	0.00549	CbGpPWpGaD
Procainamide—ACHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.000898	0.00545	CbGpPWpGaD
Procainamide—SCN11A—Axon guidance—VAV3—hypothyroidism	0.00089	0.0054	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CLTC—hypothyroidism	0.000883	0.00536	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CLTC—hypothyroidism	0.000883	0.00536	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—CLTC—hypothyroidism	0.00087	0.00528	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—SLC5A7—hypothyroidism	0.000856	0.0052	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000844	0.00513	CbGpPWpGaD
Procainamide—SCN8A—Axon guidance—VAV3—hypothyroidism	0.000814	0.00494	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000806	0.0049	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000806	0.00489	CbGpPWpGaD
Procainamide—BCHE—Phospholipid metabolism—PIK3C2A—hypothyroidism	0.000801	0.00486	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—SLC5A7—hypothyroidism	0.000798	0.00484	CbGpPWpGaD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000765	0.00465	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000751	0.00456	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—NKX2-5—hypothyroidism	0.000739	0.00449	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000734	0.00446	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000731	0.00444	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00072	0.00437	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—VAV3—hypothyroidism	0.000713	0.00433	CbGpPWpGaD
Procainamide—SCN5A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000709	0.00431	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.0007	0.00425	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—NEFL—hypothyroidism	0.000692	0.0042	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000671	0.00407	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—THRB—hypothyroidism	0.000669	0.00406	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—VAV3—hypothyroidism	0.000658	0.004	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—VAV3—hypothyroidism	0.000635	0.00386	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—VAV3—hypothyroidism	0.00063	0.00382	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CLTC—hypothyroidism	0.000621	0.00377	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—NEFL—hypothyroidism	0.000618	0.00375	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000608	0.00369	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000606	0.00368	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—VAV3—hypothyroidism	0.000605	0.00367	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—VAV3—hypothyroidism	0.000605	0.00367	CbGpPWpGaD
Procainamide—SLC22A4—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000603	0.00366	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—VAV3—hypothyroidism	0.000583	0.00354	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—VAV3—hypothyroidism	0.000583	0.00354	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—POMC—hypothyroidism	0.000582	0.00353	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—VAV3—hypothyroidism	0.000581	0.00353	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000577	0.0035	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000575	0.00349	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000574	0.00348	CbGpPWpGaD
Procainamide—ACHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.000559	0.0034	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—NEFL—hypothyroidism	0.000552	0.00335	CbGpPWpGaD
Procainamide—BCHE—Peptide hormone metabolism—POMC—hypothyroidism	0.000519	0.00315	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—NEFL—hypothyroidism	0.000514	0.00312	CbGpPWpGaD
Procainamide—BCHE—Peptide hormone metabolism—IGF1—hypothyroidism	0.000499	0.00303	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—IYD—hypothyroidism	0.000496	0.00301	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—VAV3—hypothyroidism	0.00047	0.00285	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00046	0.00279	CbGpPWpGaD
Procainamide—SLC22A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000454	0.00276	CbGpPWpGaD
Procainamide—SLC22A5—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000453	0.00275	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—VAV3—hypothyroidism	0.000449	0.00273	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VAV3—hypothyroidism	0.000432	0.00262	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VAV3—hypothyroidism	0.000432	0.00262	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000429	0.0026	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—ATP5O—hypothyroidism	0.000422	0.00256	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VAV3—hypothyroidism	0.000416	0.00253	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VAV3—hypothyroidism	0.000416	0.00253	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VAV3—hypothyroidism	0.00041	0.00249	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000399	0.00242	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TPO—hypothyroidism	0.000396	0.00241	CbGpPWpGaD
Procainamide—ACHE—Metabolism—IYD—hypothyroidism	0.00039	0.00237	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000389	0.00236	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000381	0.00232	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000366	0.00222	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000362	0.0022	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000355	0.00216	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000355	0.00216	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000355	0.00216	CbGpPWpGaD
Procainamide—BCHE—Metabolism—IYD—hypothyroidism	0.000348	0.00211	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000337	0.00205	CbGpPWpGaD
Procainamide—ACHE—Metabolism—ATP5O—hypothyroidism	0.000332	0.00202	CbGpPWpGaD
Procainamide—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000315	0.00191	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TPO—hypothyroidism	0.000312	0.00189	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—IYD—hypothyroidism	0.000311	0.00189	CbGpPWpGaD
Procainamide—SLC22A4—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000306	0.00186	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—TRH—hypothyroidism	0.000304	0.00184	CbGpPWpGaD
Procainamide—BCHE—Metabolism—ATP5O—hypothyroidism	0.000296	0.0018	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000293	0.00178	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000293	0.00178	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VAV3—hypothyroidism	0.000293	0.00178	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000292	0.00178	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—IYD—hypothyroidism	0.00029	0.00176	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000289	0.00176	CbGpPWpGaD
Procainamide—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000285	0.00173	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—TSHB—hypothyroidism	0.00028	0.0017	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TPO—hypothyroidism	0.000278	0.00169	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—TSHB—hypothyroidism	0.000271	0.00164	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—TSHR—hypothyroidism	0.000271	0.00164	CbGpPWpGaD
Procainamide—SLC22A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000266	0.00161	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—ATP5O—hypothyroidism	0.000264	0.00161	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000258	0.00157	CbGpPWpGaD
Procainamide—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000255	0.00155	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—TSHB—hypothyroidism	0.00025	0.00152	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TPO—hypothyroidism	0.000249	0.00151	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—ATP5O—hypothyroidism	0.000246	0.0015	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TPO—hypothyroidism	0.000232	0.00141	CbGpPWpGaD
Procainamide—SLC22A3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000231	0.0014	CbGpPWpGaD
Procainamide—SLC22A5—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00023	0.0014	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00021	0.00127	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000184	0.00112	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—TSHB—hypothyroidism	0.000184	0.00111	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—POMC—hypothyroidism	0.000175	0.00106	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TRH—hypothyroidism	0.000172	0.00104	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000171	0.00104	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3C2A—hypothyroidism	0.000164	0.000993	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—IYD—hypothyroidism	0.00016	0.000972	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—AVP—hypothyroidism	0.00016	0.000969	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TRH—hypothyroidism	0.000156	0.000946	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TSHB—hypothyroidism	0.000153	0.000929	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—TSHR—hypothyroidism	0.000153	0.000929	CbGpPWpGaD
Procainamide—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000145	0.000879	CbGpPWpGaD
Procainamide—ACHE—Metabolism—TSHB—hypothyroidism	0.000144	0.000877	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000139	0.000845	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TSHB—hypothyroidism	0.000139	0.000843	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—TSHR—hypothyroidism	0.000139	0.000843	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—SLC5A5—hypothyroidism	0.000137	0.000834	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000136	0.000827	CbGpPWpGaD
Procainamide—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000136	0.000824	CbGpPWpGaD
Procainamide—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000135	0.00082	CbGpPWpGaD
Procainamide—BCHE—Metabolism—TSHB—hypothyroidism	0.000129	0.000783	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3C2A—hypothyroidism	0.000129	0.000782	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TPO—hypothyroidism	0.000128	0.000777	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000127	0.000771	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—TSHB—hypothyroidism	0.000115	0.000699	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3C2A—hypothyroidism	0.000115	0.000697	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000113	0.000688	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—POMC—hypothyroidism	0.00011	0.000667	CbGpPWpGaD
Procainamide—ACHE—Metabolism—SLC5A5—hypothyroidism	0.000108	0.000657	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—TSHB—hypothyroidism	0.000107	0.000651	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CLTC—hypothyroidism	0.000107	0.000647	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—POMC—hypothyroidism	0.000106	0.000644	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—IGF1—hypothyroidism	0.000106	0.000641	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	0.000103	0.000623	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—POMC—hypothyroidism	9.79e-05	0.000595	CbGpPWpGaD
Procainamide—BCHE—Metabolism—SLC5A5—hypothyroidism	9.65e-05	0.000586	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	9.56e-05	0.000581	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—IGF1—hypothyroidism	9.42e-05	0.000572	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—VAV3—hypothyroidism	9.36e-05	0.000568	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TRH—hypothyroidism	9.21e-05	0.000559	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AVP—hypothyroidism	9.02e-05	0.000547	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—SLC5A5—hypothyroidism	8.62e-05	0.000523	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—VAV3—hypothyroidism	8.5e-05	0.000516	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TSHB—hypothyroidism	8.21e-05	0.000498	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TSHR—hypothyroidism	8.21e-05	0.000498	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AVP—hypothyroidism	8.19e-05	0.000497	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—SLC5A5—hypothyroidism	8.03e-05	0.000488	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SH2B3—hypothyroidism	7.31e-05	0.000444	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POMC—hypothyroidism	7.19e-05	0.000436	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—POMC—hypothyroidism	5.99e-05	0.000364	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—TSHB—hypothyroidism	5.93e-05	0.00036	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POMC—hypothyroidism	5.66e-05	0.000344	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—POMC—hypothyroidism	5.44e-05	0.00033	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PRL—hypothyroidism	5.43e-05	0.000329	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	5.28e-05	0.000321	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POMC—hypothyroidism	5.05e-05	0.000306	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VAV3—hypothyroidism	5.02e-05	0.000305	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AVP—hypothyroidism	4.84e-05	0.000294	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POMC—hypothyroidism	4.51e-05	0.000274	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SLC5A5—hypothyroidism	4.44e-05	0.000269	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POMC—hypothyroidism	4.2e-05	0.000255	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—POMC—hypothyroidism	3.21e-05	0.000195	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1—hypothyroidism	3.09e-05	0.000188	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POMC—hypothyroidism	2.32e-05	0.000141	CbGpPWpGaD
